Furthermore, the co-administration of DOPE/CHEMS and Tubastatin A resulted in a highly significant increase in the number of EGFP positive MSC (∼70%, Figure 5C ), which was not due to low speed deposition of polyplexes.
← all excerpts
Enhanced non-viral gene delivery by coordinated endosomal release and inhibition of β-tubulin deactylase.
1
—
—